Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New centre launched to investigate link between human sugars and disease

28.04.2005


A multidisciplinary centre launched today will promote a far broader understanding of the role sugars play in human disease, scientists say.



Focused on glycobiology, the study of how sugars in human cells affect our biology, researchers hope it will accelerate the development of therapies for diseases such as HIV, cancers and muscular dystrophy.

The Glycobiology Training, Research and Infrastructure Centre (GlycoTRIC), established at Imperial College London, will promote research at the interface between biochemistry and medicine with the aim of pushing forward both knowledge in this area and its application. This in turn will foster an ideal environment for training the next generation of researchers, according to the head of the Centre, Professor Anne Dell, who explains:


“Glycobiology is an extremely broad subject, since the way sugars work can only be fully understood within the context of the whole body. This is the first centre in the UK to bring together experts in areas such as biochemistry, genetics and physiology and promises to revolutionise our understanding of human disease.”

The study of glycobiology is based on understanding the specific biological functions of the complex mixtures of sugars found in cells. The key focus of GlycoTRIC will be to increase our understanding of what these functions are and how they are performed, leading ultimately to concrete applications in medicine and biotechnology.

Inhibition of the sugar-mediated interaction between HIV and certain cell receptors, for example, has the potential to disrupt the infection in its earliest stages. Advances in glycobiology could also greatly improve cancer treatments by enabling medics to identify changes in levels of sugars that distinguish normal and tumour cells, offering opportunities for specifically targeted drugs.

Professor Dell says: “The knowledge we develop at the Centre will be a hugely important foundation for emerging therapies for a range of chronic conditions. As we gain a greater understanding of how the body works at a cellular level, we can create ways to focus therapies that overcome diseases at their earliest stages.”

The Centre is formally launched on 28 April with a lecture delivered by Professor Mike Ferguson of the University of Dundee entitled ‘Parasite glycobiology: understanding the enemy’.

Abigail Smith | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>